EFNS/MDS-ES/ENS [corrected] recommendations for the diagnosis of Parkinson's disease. - Wikidata - wikimedia - TriplyDB

EFNS/MDS-ES/ENS [corrected] recommendations for the diagnosis of Parkinson's disease.

EFNS/MDS-ES/ENS [corrected] recommendations for the diagnosis of Parkinson's disease.

http://www.wikidata.org/entity/Q30583771

about

Toward precision medicine in Parkinson's disease Changes in Olfactory Bulb Volume in Parkinson's Disease: A Systematic Review and Meta-Analysis Parkinsonian syndromes Transcranial brain parenchymal sonography in neurodegenerative and psychiatric diseases Usefulness of Genetic Testing in PD and PD Trials: A Balanced Review Parkinson's Disease and Its Management: Part 1: Disease Entity, Risk Factors, Pathophysiology, Clinical Presentation, and Diagnosis Precompetitive Data Sharing as a Catalyst to Address Unmet Needs in Parkinson's Disease The heterozygous A53T mutation in the alpha-synuclein gene in a Chinese Han patient with Parkinson disease: case report and literature review.MR-guided focused ultrasound: a new generation treatment of Parkinson's disease, essential tremor and neuropathic pain.Ultrasonographic (TCS) and clinical findings in overlapping phenotype of essential tremor and Parkinson's disease (ET-PD)Cardiac Iodine-123-Meta-Iodo-Benzylguanidine Uptake in Carotid Sinus Hypersensitivity Levodopa-responsive depression associated with corticobasal degeneration: a case report Olfactory Impairment in Parkinson's Disease Studied with Diffusion Tensor and Magnetization Transfer Imaging.Rotigotine is safe and efficacious in Atypical Parkinsonism Syndromes induced by both α-synucleinopathy and tauopathy.Abnormal Temporal Coupling of Tactile Perception and Motor Action in Parkinson's Disease.metabolic profiling of Parkinson's disease and mild cognitive impairment.Is ioflupane I123 injection diagnostically effective in patients with movement disorders and dementia? Pooled analysis of four clinical trials.Hippocampal subfield atrophy in relation to cerebrospinal fluid biomarkers and cognition in early Parkinson's disease: a cross-sectional study.The genetic background of Parkinson's disease: current progress and future prospects.A wearable proprioceptive stabilizer (Equistasi®) for rehabilitation of postural instability in Parkinson's disease: a phase II randomized double-blind, double-dummy, controlled study.Meta-analysis of dorsolateral nigral hyperintensity on magnetic resonance imaging as a marker for Parkinson's disease.Unbiased approaches to biomarker discovery in neurodegenerative diseases Gut microbiota are related to Parkinson's disease and clinical phenotype.Ceruloplasmin functional changes in Parkinson's disease-cerebrospinal fluid Abnormal Salivary Total and Oligomeric Alpha-Synuclein in Parkinson's Disease.Guidelines for dementia or Parkinson's disease with depression or anxiety: a systematic review.The role of high-field magnetic resonance imaging in parkinsonian disorders: Pushing the boundaries forward.Multivariate Analysis of 18F-DMFP PET Data to Assist the Diagnosis of Parkinsonism A Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease Heterogeneity of Monosymptomatic Resting Tremor in a Prospective Study: Clinical Features, Electrophysiological Test, and Dopamine Transporter Positron Emission Tomography.Evaluation of Nonmotor Symptoms in Diagnosis of Parkinsonism and Tremor.Neuropsychological Profiles in Mild Cognitive Impairment due to Alzheimer's and Parkinson's Diseases Nigrosome-1 on Susceptibility Weighted Imaging to Differentiate Parkinson's Disease From Atypical Parkinsonism: An In Vivo and Ex Vivo Pilot Study The predictive value of SS-16 in clinically diagnosed Parkinson's disease patients: comparison with (99m)Tc-TRODAT-1 SPECT scans.Altered Kinematics of Facial Emotion Expression and Emotion Recognition Deficits Are Unrelated in Parkinson's Disease.Ascertainment bias in dementias: a secondary to tertiary centre analysis in Central Italy and conceptual review.Recent developments in biomarkers in Parkinson disease Cardiac metaiodobenzylguanidine imaging and heart failure.Clinical syndromes: Parkinsonian gait.Early versus delayed initiation of pharmacotherapy in Parkinson's disease.

P2860

Q26764954-137096D9-8D23-4F15-84BB-3182CFAF484E Q26768485-CE70AA2F-BDC4-47FC-B114-3E70CF0F9B79 Q27007524-CF6335C5-21F2-43D9-8377-D2BC80769BB0 Q27026684-53C997C7-EA6B-47AF-A4DF-E6251560DD62 Q28085293-5BEE983A-2728-40CA-B276-4CE5BCFCDA9E Q28384572-FBB58182-0F04-4C7E-A10D-4FC8CDF2680F Q28601965-99CC75DA-2DA8-4279-B4D7-794D4B96B165 Q30249098-807E3146-C521-4FBC-9B41-E6724CC82695 Q30393753-211AEDC4-8920-4AD5-BD8E-0AD30E7B40AC Q30439600-472E4E00-6CDB-4989-A41D-1096AAF7922C Q33165838-93AB528A-F965-4BC9-9120-72F94909C9B0 Q33596836-D76BC355-D363-41CF-8661-A5E0FC092BFE Q33708913-59D28BB7-8866-4AEC-A566-BA53D0D4AEC1 Q33734770-D0722615-BD4E-49C3-A792-BAD5AF2BBC7D Q33766092-7E488225-4B94-4661-8117-5C2F2ADA43BB Q33835701-ABC19DE8-9AD3-4AAF-BD25-D1C185E7B80C Q33879821-95B683C4-B88F-4B70-81F2-EDF83CC70857 Q33917300-238D253F-7AFB-4F50-89D2-87048AF3FC2D Q34513714-53590E06-C9F3-4E73-A315-B6367F767B50 Q34527110-DDF1EE11-9AAF-47C2-B81F-A24B62986F78 Q34550489-7AAF2CA1-7134-407C-90D2-02EE30FBA106 Q34625918-A2183040-0F90-49DE-B90E-71F3B190EA75 Q35492461-C91A4C14-4996-49C9-B167-953348CFE592 Q35832847-95DA7D52-8702-4BEA-A202-3E9424C27D3D Q35969183-B1DEFC40-4797-459B-9AD9-7BFAA3E50D58 Q36204169-81181A1A-81EF-4A23-AC29-56EF0140660F Q36332532-DDE21242-F7A7-4D73-B20F-9E285DD613E2 Q36351415-F6EF9FDD-AB49-44C5-9E3E-9716DEEB949E Q36460985-AE96F9AF-0EE3-49BA-B72E-7085ACE49775 Q36523068-ABE5590A-8900-4ED3-B306-7FF543C01107 Q37043936-3547EA5F-DE86-4417-96FB-55517EBA58A7 Q37053721-7EDB7FE7-3E82-4CCB-803A-CF0B23217FC2 Q37155510-30C7A082-5561-4D40-AB21-29A3F0313D1B Q37192609-50F39E95-7AB9-4F50-BDE2-00574187B365 Q37500580-25D19EA8-FABE-46CF-8E22-C468AFFD2B26 Q38115735-BA2942E5-BBED-46EB-9A6D-312541EC087D Q38119095-50BBE34B-1C1A-464E-8547-41EE0CEBEB05 Q38148977-C62192C8-743B-4B75-8AB0-BAEF725CDE40 Q38153328-43EF842C-9B34-4F36-8C68-1348EA6487D9 Q38206403-85628586-85B4-4743-9914-2EFB369A14A4

P2860

EFNS/MDS-ES/ENS [corrected] recommendations for the diagnosis of Parkinson's disease.

http://www.wikidata.org/entity/Q30583771

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

EFNS/MDS-ES/ENS [corrected] recommendations for the diagnosis of Parkinson's disease.

@ast

EFNS/MDS-ES/ENS [corrected] recommendations for the diagnosis of Parkinson's disease.

@en

type

label

EFNS/MDS-ES/ENS [corrected] recommendations for the diagnosis of Parkinson's disease.

@ast

EFNS/MDS-ES/ENS [corrected] recommendations for the diagnosis of Parkinson's disease.

@en

prefLabel

EFNS/MDS-ES/ENS [corrected] recommendations for the diagnosis of Parkinson's disease.

@ast

EFNS/MDS-ES/ENS [corrected] recommendations for the diagnosis of Parkinson's disease.

@en

P1433

Q30583771-75F05591-F284-467C-A201-1CC94A642944

P1476

Q30583771-77294226-C2B3-48D8-9C58-7E5B483E5116

P2093

Q30583771-0147562B-4DBF-443F-AC6A-45B7309233D0

Q30583771-26F96B17-3CA2-47E9-948B-DB6C22E874BA

Q30583771-28F16C9D-64A3-4206-A153-BDCC52F7631E

Q30583771-304B474D-01CD-4132-B7E2-F45695362D1B

Q30583771-5F6BF418-F52E-403D-92D1-176178D57631

Q30583771-6103B903-2587-4BF5-AA4E-48777A20B456

Q30583771-6491FC60-F398-43CB-910E-9B7343ED4C21

Q30583771-73FE4B35-D456-4A85-B7A5-4455A4629CD8

Q30583771-78EB73FE-FC95-4AB1-B85A-902D824DCEFB

Q30583771-7D2B128A-57FF-409B-9E1B-C99351515A99

P304

Q30583771-AE7641AE-0CAF-4493-AF1B-44C07D4AF751

P31

Q30583771-A5EAD7E0-AFF1-4D0D-8875-2DDB0AC71BB4

P356

Q30583771-186D838E-42AD-4F3D-A147-404AA959535A

P433

Q30583771-2ECFC85C-3C1B-440A-A61B-13CF11D93D19

P478

Q30583771-3B46AC9E-6117-492E-BE35-2EF036C0269C

P50

Q30583771-09B29034-6298-48F5-A612-0E84C2104207

Q30583771-1B25BC0D-B249-4F2D-90B7-FB2BB9119720

Q30583771-62D6FA8A-773D-41F7-AE6C-1909800E8974

Q30583771-835BCB2A-47E7-4D74-BE16-0EF3080F49F3

P577

Q30583771-463D0A71-2844-4210-BBA6-1FD93596E088

P5875

Q30583771-37366C0F-3F1A-4882-B396-1CD7B30B9630

P698

Q30583771-9861DA28-07EC-427D-A14A-925FC7B4E309

P921

Q30583771-26786EC0-D668-4701-BBF7-31E7FA24D02C

P356

P1433

European Journal of Neurology

P1476

EFNS/MDS-ES/ENS [corrected] recommendations for the diagnosis of Parkinson's disease.

@en

P2093

A Berardelli

http://www.w3.org/2001/XMLSchema#string

A Fanciulli

http://www.w3.org/2001/XMLSchema#string

A Schrag

http://www.w3.org/2001/XMLSchema#string

B R Bloem

http://www.w3.org/2001/XMLSchema#string

D Berg

http://www.w3.org/2001/XMLSchema#string

D Brooks

http://www.w3.org/2001/XMLSchema#string

D J Burn

http://www.w3.org/2001/XMLSchema#string

E Ruzicka

http://www.w3.org/2001/XMLSchema#string

F Grandas

http://www.w3.org/2001/XMLSchema#string

G K Wenning

http://www.w3.org/2001/XMLSchema#string

P304

16-34

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/ENE.12022

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

Wolfgang H. Oertel

Angelo Antonini

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

234031001

http://www.w3.org/2001/XMLSchema#string

P698

23279440

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease